Valuation: Navamedic ASA

Market Cap 32Cr 3.31Cr 2.94Cr 2.75Cr 2.5Cr 4.72Cr 318.52Cr 4.77Cr 33Cr 13Cr 162.83Cr 12Cr 12Cr 522.59Cr P/E 2026 *
-49.6x
P/E 2027 * 42.6x
Enterprise Value 44Cr 4.55Cr 4.05Cr 3.78Cr 3.44Cr 6.49Cr 437.86Cr 6.55Cr 46Cr 18Cr 223.84Cr 17Cr 17Cr 718.38Cr EV / Sales 2026 *
0.77x
EV / Sales 2027 * 0.69x
Free-Float
30.5%
Yield 2026 *
-
Yield 2027 * -
1 day-1.48%
1 week-0.37%
Current month-3.27%
1 month-2.92%
3 months-21.76%
6 months-32.83%
Current year-44.12%
1 week 13.25
Extreme 13.25
13.9
1 month 13.05
Extreme 13.05
14.1
Current year 13.05
Extreme 13.05
24.5
1 year 13.05
Extreme 13.05
26.5
3 years 13.05
Extreme 13.05
43.9
5 years 13.05
Extreme 13.05
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 55 18/06/2026
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 60 01/06/2024
Chairman 66 -
Director/Board Member 68 23/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/24 Buy

Chief Operating Officer

10,267 0.0581%
09/09/24 Exercice

Chief Executive Officer

80,000 0.4589%
09/09/24 Exercice

Chief Operating Officer

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-0.37%-38.14%-64.81% 3.31Cr
-0.61%-3.43%+36.07%+117.61% 1,01900Cr
-1.02%-5.60%+35.72%+64.82% 62TCr
+1.11%-0.58%+12.36%+78.27% 46TCr
+0.34%-3.01%+61.79%+41.79% 36TCr
-0.95%-4.05%+20.54%+40.33% 33TCr
-1.46%-2.89%+10.57%+26.54% 27TCr
-1.35%-5.43%-6.17%+8.82% 24TCr
-1.04%-2.79%+35.30%+54.42% 22TCr
-1.87%-4.10%+28.44%+97.54% 18TCr
Average -0.83%-3.09%+19.65%+46.53% 36.97TCr
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2026 *2027 *
Net sales 57Cr 5.92Cr 5.26Cr 4.91Cr 4.47Cr 8.44Cr 569.06Cr 8.52Cr 59Cr 23Cr 290.91Cr 22Cr 22Cr 933.64Cr 60Cr 6.27Cr 5.57Cr 5.2Cr 4.74Cr 8.94Cr 603.13Cr 9.03Cr 63Cr 24Cr 308.33Cr 24Cr 23Cr 989.54Cr
Net income -64.96L -7L -6L -6L -5L -10L -6.49Cr -10L -67.72L -26.24L -3.32Cr -25.34L -24.79L -11Cr 76.98L 8L 7L 7L 6L 11.4L 7.69Cr 11.51L 80.25L 31.1L 3.93Cr 30.02L 29.37L 13Cr
Net Debt 12Cr 1.24Cr 1.1Cr 1.03Cr 93.83L 1.77Cr 119.34Cr 1.79Cr 12Cr 4.83Cr 61Cr 4.66Cr 4.56Cr 195.79Cr 9.69Cr 1.01Cr 89.44L 83.48L 76.09L 1.43Cr 97Cr 1.45Cr 10Cr 3.91Cr 49Cr 3.78Cr 3.7Cr 158.77Cr
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
02/26/02 NOK 13.30 -1.48% 4,744
01/26/01 NOK 13.50 -1.82% 5,321
30/26/30 NOK 13.75 +1.10% 11,906
29/26/29 NOK 13.60 +2.26% 9,441
28/26/28 NOK 13.30 -0.37% 14,669
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.30NOK
Average target price
21.00NOK
Spread / Average Target
+57.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock